Related Experiment Video
Updated: Jun 12, 2026
Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
Published on: June 28, 2024
Persistent Benefits of Early Gestational Chenodeoxycholic Acid Supplementation on Late Pregnancy in Sows via
Ying Zhao1, Xiaolong Wang2, Qian Ma2
1Animal Sciences, TERRA Teaching and Research Centre, Gembloux Agro-Bio Tech, University of Liège, Gembloux, Belgium.
Background:
Our previous studies in pigs have identified chenodeoxycholic acid (CDCA) as a potent metabolic regulator during early gestation, capable of enhancing embryo implantation by optimizing maternal metabolic status and gut microbiota-host interactions, whereas the long-term impacts of early gestational CDCA on late pregnancy remain largely unexplored.
Objectives:
This study investigated whether supplementation with CDCA during early gestation (gestational day 0-28) exerts a sustained metabolic modulation effect on maternal health and reproductive outcomes in late gestation in a sow model.
Methods:
Multiparous sows (n = 24) were randomly assigned to receive either a control diet or a diet supplemented with 0.15% CDCA during early gestation. The reproductive performance, oxidative stress, inflammatory status, gut microbiome, and serum metabolome in late gestation were subsequently evaluated.
Results:
Results showed that early CDCA intervention significantly increased the total and live litter sizes (P < 0.05). Furthermore, CDCA treatment alleviated maternal oxidative stress and systemic inflammation and improved insulin sensitivity in late gestation (P < 0.05). Untargeted metabolomics revealed a distinct metabolic remodeling, characterized by the enrichment of beneficial metabolites, such as L-ornithine, and the depletion of proinflammatory and oxidative markers, including 1-palmitoylphosphatidylcholine, 2-lysophosphatidylcholine, 3-hydroxyanthranilic acid, and N-carboxymethyllysine. 16S rRNA sequencing indicated that CDCA exerted a targeted modulation rather than a global reconstruction of the gut microbiota. Specifically, CDCA suppressed potentially harmful bacteria, including NK4A214_group, Clostridium_sensu_stricto_1, and Turicibacter, whereas it enriched beneficial genera such as Subdoligranulum. Multiomics integration identified NK4A214_group as a key driver associated with exacerbated inflammatory status and unfavorable metabolic profiles.
Conclusions:
Collectively, these findings demonstrate that early gestational CDCA supplementation elicits a long-term protective effect on maternal metabolism via optimizing specific gut microbe-metabolite interactions, thereby ensuring optimal gestational outcomes.
